Hermetica Superfood Encyclopedia
The Short Answer
Amazonian Cinnamon (Ocotea quixos), commonly known as ishpingo, is a Lauraceae-family tree native to the Ecuadorian Amazon whose bark is rich in trans-cinnamaldehyde, methyl cinnamate, and 1,8-cineole—compounds that inhibit NF-κB-mediated inflammatory signaling and activate the Nrf2 antioxidant pathway. While no dedicated clinical trials on O. quixos appear in PubMed, its cinnamaldehyde content parallels well-studied Cinnamomum species shown to improve insulin sensitivity, lower fasting blood glucose, and reduce LDL cholesterol in human trials.
CategoryBark
GroupBark
Evidence LevelStrong
Primary Keywordamazonian cinnamon benefits
Synergy Pairings4
Amazonian Cinnamon — botanical close-up
Health Benefits
Regulates blood sugar levels and improves insulin sensitivity through cinnamaldehyde and polyphenol activity.
Enhances cardiovascular health and circulation by improving vascular function and lowering LDL cholesterol.
Reduces inflammation and alleviates pain through bioactive anti-inflammatory compounds.
Promotes digestive health by supporting gut microbiota balance and relieving bloating.
Strengthens immune function and protects against oxidative damage with flavonoids, tannins, and essential oils.
Enhances cognitive function by improving memory, focus, and reducing neuroinflammation.
Origin & History
Natural habitat
Amazonian Cinnamon, derived from various *Cinnamomum* species native to the Amazon rainforest, is a distinct botanical with a rich history in indigenous traditions. It is valued for its unique profile of cinnamaldehyde and polyphenols, offering significant benefits for metabolic, cardiovascular, and cognitive health.
“Amazonian Cinnamon has been historically used by Indigenous Amazonian tribes for centuries. It was traditionally brewed into herbal tonics and decoctions for regulating blood sugar, improving circulation, supporting digestion, and enhancing metabolic vitality within their communities.”Traditional Medicine
Scientific Research
No species-specific PubMed clinical trials on Ocotea quixos (Amazonian Cinnamon / ishpingo) have been published to date, making direct citation of controlled human studies impossible at this time. However, phytochemical analyses have confirmed that the bark and leaves of O. quixos contain trans-cinnamaldehyde (up to 45% of essential oil composition), methyl cinnamate, and 1,8-cineole, overlapping significantly with bioactive profiles of Cinnamomum verum and C. cassia that have been extensively studied. Broader cinnamon research—including meta-analyses of randomized controlled trials—demonstrates that cinnamaldehyde-rich extracts can reduce fasting blood glucose by 24.59 mg/dL and lower LDL cholesterol. Rigorous human clinical trials specifically on Amazonian Cinnamon are needed to confirm whether its traditional Amazonian medicinal applications translate into clinically validated outcomes.
Preparation & Dosage
Traditional preparation
Extract Form
000 mg of Amazonian cinnamon extract daily for metabolic and cardiovascular support
500–1,.
Powdered Form
1–2 grams of powder for digestive and anti-inflammatory benefits, often consumed in teas or foods.
Traditional Use
Historically brewed into herbal tonics and decoctions by Indigenous Amazonian tribes.
Nutritional Profile
- Cinnamaldehyde: Key bioactive compound for metabolic and anti-inflammatory effects.
- Polyphenols, Flavonoids, Tannins: Potent antioxidants and anti-inflammatory agents.
- Essential Oils, Terpenes: Contribute to aromatic profile and therapeutic properties.
How It Works
Mechanism of Action
Trans-cinnamaldehyde, the primary bioactive compound in Amazonian Cinnamon bark, suppresses the NF-κB and AP-1 transcription factor pathways by inhibiting IκB kinase (IKK) phosphorylation, thereby reducing expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Simultaneously, cinnamaldehyde activates the Keap1-Nrf2-ARE signaling axis, upregulating phase II detoxification enzymes such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferase (GST), conferring potent antioxidant cytoprotection. Regarding glucose metabolism, cinnamaldehyde enhances insulin receptor substrate-1 (IRS-1) phosphorylation and stimulates GLUT4 translocation to the cell membrane in skeletal muscle and adipose tissue, improving peripheral glucose uptake. Additional constituents including methyl cinnamate and polyphenolic proanthocyanidins contribute to α-glucosidase and α-amylase inhibition, delaying carbohydrate digestion and postprandial glycemic spikes.
Clinical Evidence
Current evidence for Amazonian Cinnamon is primarily based on preclinical in vitro and animal studies, with limited human clinical trials available. In rat Parkinson's models, cinnamon extracts increased striatal dopamine by 17-49% and reduced oxidative stress markers by 15-22%. Antioxidant studies show IC50 values of 1.771 mg/mL for DPPH and 0.060 mg/mL for ABTS radical scavenging. Human clinical trials are needed to validate these preclinical findings and establish therapeutic dosages.
Safety & Interactions
Amazonian Cinnamon bark contains coumarin at lower levels than Cinnamomum cassia, but prolonged high-dose consumption may still pose hepatotoxicity risk in sensitive individuals; the European Food Safety Authority (EFSA) established a tolerable daily intake of 0.1 mg coumarin per kg body weight. Cinnamaldehyde-rich preparations may potentiate the effects of antidiabetic medications (metformin, sulfonylureas, insulin), increasing hypoglycemia risk, and may enhance anticoagulant activity of warfarin and other blood thinners due to mild antiplatelet properties. In vitro evidence suggests cinnamaldehyde can inhibit CYP2A6 and CYP2E1 enzymes, potentially altering metabolism of substrates processed by these isoforms; individuals on medications metabolized by these pathways should consult a healthcare provider. Pregnant and breastfeeding women should avoid therapeutic doses due to insufficient safety data, and individuals with liver disease should exercise caution.
Synergy Stack
Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Cardio & Circulation | Gut & Microbiome
Featured in
Cozy
Warming adaptogenic blend for comfort and calm.
Shop Now →
Also Known As
Cinnamomum parvicompactumWild Amazon CinnamonAmazonian CassiaRainforest Cinnamon
Frequently Asked Questions
What is Amazonian Cinnamon (ishpingo) and how is it different from regular cinnamon?
Amazonian Cinnamon comes from Ocotea quixos, a Lauraceae-family tree native to the Ecuadorian and Colombian Amazon, whereas common cinnamon comes from Cinnamomum verum (Ceylon) or C. cassia. While both contain trans-cinnamaldehyde, ishpingo bark also features significant concentrations of methyl cinnamate and 1,8-cineole, giving it a distinct aromatic profile and potentially different pharmacological effects. Indigenous Kichwa communities have used ishpingo bark for centuries in traditional medicine and as a culinary spice.
What are the main health benefits of Amazonian Cinnamon bark?
Amazonian Cinnamon bark is traditionally used and phytochemically supported for blood sugar regulation, anti-inflammatory activity, antioxidant protection, digestive support, and cardiovascular health. Its cinnamaldehyde content parallels compounds shown in broader cinnamon research to reduce fasting glucose, lower LDL cholesterol, and inhibit NF-κB-driven inflammation. However, dedicated human clinical trials on O. quixos specifically are still needed to confirm these benefits at established dosages.
Can Amazonian Cinnamon help lower blood sugar levels?
The trans-cinnamaldehyde in Amazonian Cinnamon enhances insulin receptor signaling and promotes GLUT4-mediated glucose uptake in muscle and fat cells, mechanisms well-documented in studies of related cinnamon species. Meta-analyses of cinnamaldehyde-rich cinnamon extracts have shown reductions in fasting blood glucose of up to 24.59 mg/dL in type 2 diabetes patients. While these findings are promising, people taking diabetes medications should consult their physician before using Amazonian Cinnamon therapeutically due to potential additive hypoglycemic effects.
How do you use ishpingo bark traditionally in the Amazon?
Indigenous Kichwa and other Amazonian communities traditionally use ishpingo bark as a decoction (boiled tea) for digestive complaints, colds, and general wellness, and as a warming aromatic spice in foods and ceremonial beverages including colada morada and chicha. The bark is typically simmered in water for 10–20 minutes to extract its volatile oils and polyphenols. It is also used in spiritual and ceremonial contexts as an aromatic incense and purification agent.
Is Amazonian Cinnamon safe to consume daily?
For most healthy adults, moderate daily consumption of Amazonian Cinnamon bark tea or culinary amounts is considered generally safe, though no formal recommended daily allowance exists for O. quixos specifically. The European Food Safety Authority caps coumarin intake at 0.1 mg/kg body weight per day; ishpingo generally contains less coumarin than cassia cinnamon but amounts can vary. Individuals on blood thinners, diabetes medications, or with liver conditions should consult a healthcare provider before regular use.
Does Amazonian Cinnamon interact with diabetes medications or blood sugar drugs?
Amazonian Cinnamon may have additive blood sugar-lowering effects when combined with diabetes medications like metformin or insulin, potentially increasing hypoglycemia risk. If you are taking prescription diabetes medications, consult your healthcare provider before adding Amazonian Cinnamon supplements to monitor blood sugar levels closely. Dosage adjustments to medications may be necessary when combining these treatments.
What is the recommended daily dosage of Amazonian Cinnamon bark, and when should I take it?
Typical dosing ranges from 1–3 grams of dried bark powder daily, often divided into 2–3 doses taken with meals to enhance absorption and minimize digestive upset. Taking Amazonian Cinnamon with food also helps stabilize blood sugar levels throughout the day and reduces the risk of nausea. For best results, consistency is more important than timing, so choose a routine you can maintain daily.
Who should avoid Amazonian Cinnamon, and is it safe for pregnant women or children?
Pregnant and breastfeeding women should avoid Amazonian Cinnamon due to insufficient safety data, as it may have mild uterine stimulant properties. Children may use it in small amounts under parental supervision, but dosing should be adjusted based on age and weight. Individuals with cinnamon allergies, severe liver disease, or those scheduled for surgery should also consult a healthcare provider before use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w amazonian-cinnamon curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
